Compare $ADTX vs $VCNX | Chartloom

Compare

$ADTX vs $VCNX

Aditxt Inc · Vaccinex Inc

ADTX

Aditxt Inc

VCNX

Vaccinex Inc

Compare $ADTX vs $VCNX

Comparing Aditxt Inc and Vaccinex Inc

ADTXAditxt Inc

VCNXVaccinex Inc

ADTXAditxt Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-74.0%

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

-186.2%

VCNXVaccinex Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.4%

YTD performance

0.9%

52W performance

29.8%

FCF yield

-530.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADTX

VCNX

Detailed metrics comparison

ADTX

Aditxt Inc

VCNX

Vaccinex Inc

Market Cap

ADTX$10M

VCNX$3M

Enterprise Value

ADTX$13M

VCNX$2M

Price

ADTX$0.01

VCNX$1.14

P/E Ratio

ADTXN/A

VCNXN/A

P/S Ratio

ADTX693.04x

VCNX5.08x

EV/Sales

ADTX903.97x

VCNX3.28x

EV/EBITDA

ADTX0.00x

VCNX0.00x

P/B Ratio

ADTX0.53x

VCNX1.15x

P/FCF Ratio

ADTXN/A

VCNXN/A

EV/FCF

ADTX-0.70x

VCNX-0.12x

PEG Ratio

ADTXN/A

VCNXN/A

Forward P/E (NTM)

ADTXN/A

VCNXN/A

Forward P/S (NTM)

ADTXN/A

VCNXN/A

Revenue (TTM)

ADTX$14K

VCNX$601K

Revenue Growth (YoY)

ADTX-74.0%

VCNX5.4%

Forward Rev Growth

ADTX0.0%

VCNX0.0%

Gross Margin (TTM)

ADTX20.1%

VCNX99.7%

Operating Margin (TTM)

ADTX0.0%

VCNX0.0%

EBITDA Margin (TTM)

ADTX-125503.5%

VCNX-3101.7%

Net Margin (TTM)

ADTX-370408.3%

VCNX-3100.5%

FCF Margin (TTM)

ADTX-129012.5%

VCNX-2696.8%

Net Income (TTM)

ADTX$-53M

VCNX$-19M

FCF (TTM)

ADTX$-19M

VCNX$-16M

EPS (TTM)

ADTX-$2,640.53

VCNX-$5.78

ROE (TTM)

ADTX-15077.0%

VCNX-14678.0%

ROA (TTM)

ADTX-27739.0%

VCNX-43375.0%

ROIC (TTM)

ADTX-11833.0%

VCNX-14238.0%

Cash

ADTX$269K

VCNX$1M

Debt

ADTX$3M

VCNX$25K

Net Cash/Debt

ADTX$-3M

VCNX$1M

Current Ratio (TTM)

ADTX0.06x

VCNX0.50x

Quick Ratio (TTM)

ADTX0.02x

VCNX0.38x

Debt/Equity (TTM)

ADTX0.33x

VCNX0.03x

Debt/Assets (TTM)

ADTX0.0%

VCNX0.0%

Interest Coverage (TTM)

ADTXN/A

VCNXN/A

Net Debt/EBITDA (TTM)

ADTX0.00x

VCNX0.00x

Beta

ADTX1.31

VCNX0.73

52W Performance

ADTX-100.0%

VCNX29.8%

YTD Performance

ADTX-100.0%

VCNX0.9%

% from 52W High

ADTX-100.0%

VCNX-24.0%

% from 52W Low

ADTXN/A

VCNX267.7%

Asset Turnover (TTM)

ADTX0.00x

VCNX0.14x

FCF Yield (TTM)

ADTX-186.2%

VCNX-530.5%

Earnings Yield (TTM)

ADTX-534.5%

VCNX-609.9%

Dividend Yield (TTM)

ADTXN/A

VCNXN/A

Rule of 40

ADTX-129,086.5

VCNX-2,691.4

EV/GP/RG

ADTXN/A

VCNXN/A

Ticker research

View ADTX research View VCNX research

Metric	ADTX Aditxt Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$10M	$3M
Enterprise Value	$13M	$2M
Price	$0.01	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	693.04x	5.08x
EV/Sales	903.97x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.70x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$14K	$601K
Revenue Growth (YoY)	-74.0%	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	20.1%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-125503.5%	-3101.7%
Net Margin (TTM)	-370408.3%	-3100.5%
FCF Margin (TTM)	-129012.5%	-2696.8%
Net Income (TTM)	$-53M	$-19M
FCF (TTM)	$-19M	$-16M
EPS (TTM)	-$2,640.53	-$5.78
ROE (TTM)	-15077.0%	-14678.0%
ROA (TTM)	-27739.0%	-43375.0%
ROIC (TTM)	-11833.0%	-14238.0%
Financial Health
Cash	$269K	$1M
Debt	$3M	$25K
Net Cash/Debt	$-3M	$1M
Current Ratio (TTM)	0.06x	0.50x
Quick Ratio (TTM)	0.02x	0.38x
Debt/Equity (TTM)	0.33x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	0.73
52W Performance	-100.0%	29.8%
YTD Performance	-100.0%	0.9%
% from 52W High	-100.0%	-24.0%
% from 52W Low	N/A	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.14x
FCF Yield (TTM)	-186.2%	-530.5%
Earnings Yield (TTM)	-534.5%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-129,086.5	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View ADTX research	View VCNX research

Valuation

P/S Ratio

VCNX

5.08x

ADTX

693.04x

EV/FCF

ADTX

-0.70x

VCNX

-0.12x

Growth & revenue

Revenue Growth TTM

VCNX

5.4%

ADTX

-74.0%

Forward Revenue Growth

ADTX

0.0%

VCNX

0.0%

Profitability & performance

Gross Margin

VCNX

99.7%

ADTX

20.1%

ROE

VCNX

-14678.0%

ADTX

-15077.0%

FCF Yield %

ADTX

-186.2%

VCNX

-530.5%

52-Week Performance

VCNX

29.8%

ADTX

-100.0%

Detailed metrics comparison

ADTX

Aditxt Inc

VCNX

Vaccinex Inc

Market Cap

ADTX$10M

VCNX$3M

Enterprise Value

ADTX$13M

VCNX$2M

Price

ADTX$0.01

VCNX$1.14

P/E Ratio

ADTXN/A

VCNXN/A

P/S Ratio

ADTX693.04x

VCNX5.08x

EV/Sales

ADTX903.97x

VCNX3.28x

EV/EBITDA

ADTX0.00x

VCNX0.00x

P/B Ratio

ADTX0.53x

VCNX1.15x

P/FCF Ratio

ADTXN/A

VCNXN/A

EV/FCF

ADTX-0.70x

VCNX-0.12x

PEG Ratio

ADTXN/A

VCNXN/A

Forward P/E (NTM)

ADTXN/A

VCNXN/A

Forward P/S (NTM)

ADTXN/A

VCNXN/A

Revenue (TTM)

ADTX$14K

VCNX$601K

Revenue Growth (YoY)

ADTX-74.0%

VCNX5.4%

Forward Rev Growth

ADTX0.0%

VCNX0.0%

Gross Margin (TTM)

ADTX20.1%

VCNX99.7%

Operating Margin (TTM)

ADTX0.0%

VCNX0.0%

EBITDA Margin (TTM)

ADTX-125503.5%

VCNX-3101.7%

Net Margin (TTM)

ADTX-370408.3%

VCNX-3100.5%

FCF Margin (TTM)

ADTX-129012.5%

VCNX-2696.8%

Net Income (TTM)

ADTX$-53M

VCNX$-19M

FCF (TTM)

ADTX$-19M

VCNX$-16M

EPS (TTM)

ADTX-$2,640.53

VCNX-$5.78

ROE (TTM)

ADTX-15077.0%

VCNX-14678.0%

ROA (TTM)

ADTX-27739.0%

VCNX-43375.0%

ROIC (TTM)

ADTX-11833.0%

VCNX-14238.0%

Cash

ADTX$269K

VCNX$1M

Debt

ADTX$3M

VCNX$25K

Net Cash/Debt

ADTX$-3M

VCNX$1M

Current Ratio (TTM)

ADTX0.06x

VCNX0.50x

Quick Ratio (TTM)

ADTX0.02x

VCNX0.38x

Debt/Equity (TTM)

ADTX0.33x

VCNX0.03x

Debt/Assets (TTM)

ADTX0.0%

VCNX0.0%

Interest Coverage (TTM)

ADTXN/A

VCNXN/A

Net Debt/EBITDA (TTM)

ADTX0.00x

VCNX0.00x

Beta

ADTX1.31

VCNX0.73

52W Performance

ADTX-100.0%

VCNX29.8%

YTD Performance

ADTX-100.0%

VCNX0.9%

% from 52W High

ADTX-100.0%

VCNX-24.0%

% from 52W Low

ADTXN/A

VCNX267.7%

Asset Turnover (TTM)

ADTX0.00x

VCNX0.14x

FCF Yield (TTM)

ADTX-186.2%

VCNX-530.5%

Earnings Yield (TTM)

ADTX-534.5%

VCNX-609.9%

Dividend Yield (TTM)

ADTXN/A

VCNXN/A

Rule of 40

ADTX-129,086.5

VCNX-2,691.4

EV/GP/RG

ADTXN/A

VCNXN/A

Ticker research

View ADTX research View VCNX research

Metric	ADTX Aditxt Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$10M	$3M
Enterprise Value	$13M	$2M
Price	$0.01	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	693.04x	5.08x
EV/Sales	903.97x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.70x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$14K	$601K
Revenue Growth (YoY)	-74.0%	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	20.1%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-125503.5%	-3101.7%
Net Margin (TTM)	-370408.3%	-3100.5%
FCF Margin (TTM)	-129012.5%	-2696.8%
Net Income (TTM)	$-53M	$-19M
FCF (TTM)	$-19M	$-16M
EPS (TTM)	-$2,640.53	-$5.78
ROE (TTM)	-15077.0%	-14678.0%
ROA (TTM)	-27739.0%	-43375.0%
ROIC (TTM)	-11833.0%	-14238.0%
Financial Health
Cash	$269K	$1M
Debt	$3M	$25K
Net Cash/Debt	$-3M	$1M
Current Ratio (TTM)	0.06x	0.50x
Quick Ratio (TTM)	0.02x	0.38x
Debt/Equity (TTM)	0.33x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	0.73
52W Performance	-100.0%	29.8%
YTD Performance	-100.0%	0.9%
% from 52W High	-100.0%	-24.0%
% from 52W Low	N/A	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.14x
FCF Yield (TTM)	-186.2%	-530.5%
Earnings Yield (TTM)	-534.5%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-129,086.5	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View ADTX research	View VCNX research